Kai Li

7.5k citations
212 papers · 5.4k · 3 hit papers · h-index 39

Impact in

    • Cancer-related molecular mechanisms research
    • MicroRNA in disease regulation
    • RNA modifications and cancer
    • Circular RNAs in diseases
    • Extracellular vesicles in disease
    • Cancer-related gene regulation
    • Epigenetics and DNA Methylation

Papers in

    • RNA modifications and cancer 46
    • Circular RNAs in diseases 22
    • Cancer-related gene regulation 20
    • Extracellular vesicles in disease 16
    • Epigenetics and DNA Methylation 12
    • Cancer-related molecular mechanisms research 53
    • MicroRNA in disease regulation 42

Kai Li

207 papers receiving 5.4k citations

Kai Li's Hit Papers

A signature of saliva-derived exosomal small RNAs as predicting biomarker for esophageal carcinoma: a multicenter prospective study 2022 · 145 citations
1450+4+8Years since publication100200300

Peers

Kai Li
Comparison fields: 5 of 148
  • Cancer Research 1.8k
  • Molecular Biology 3.2k
  • Immunology 578
  • Hepatology 217
  • Oncology 618
Replace Aimin Li with:
Aimin Li China
Caroline Bouzin Belgium
Yong Dai China
Junfeng Zhang China
Qing Miao China
Rui Xie China
Weiwei Wang China
Liang Chen China
Hua Tang China
Kai Li relative to Aimin Li China Aimin Li's profile →
Citations per field
00.5×1.5×2.0×
Aimin Li · 1×
Citations per year

Countries citing papers authored by Kai Li

Since Specialization
Citations

This map shows the geographic impact of Kai Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Li more than expected).

Fields of papers citing papers by Kai Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Li. The network helps show where Kai Li may publish in the future.

Co-authors

The 25 scholars most cited alongside Kai Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kai Li Line = papers co-authored together Kai Li links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 212 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus
Hit paper breakdown →
2014338
2 2014299
3
RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner
Hit paper breakdown →
2020285
4
A signature of saliva-derived exosomal small RNAs as predicting biomarker for esophageal carcinoma: a multicenter prospective study
Hit paper breakdown →
2022145
5 2008142
6 2022129
7 2012127
8 2019104
9 202285
10 201485
11 201985
12 201382
13 201979
14
[Recent incidences and trends of childhood malignant solid tumors in Shanghai, 2002-2010].
201378
15 201975
16 202074
17 201772
18 201972
19 201872
20 201871

About Kai Li

Kai Li is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Biomedical Engineering, having authored 212 papers that have together received 5.4k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (53 papers), RNA modifications and cancer (46 papers), MicroRNA in disease regulation (42 papers), Circular RNAs in diseases (22 papers), Cancer-related gene regulation (20 papers), Extracellular vesicles in disease (16 papers), Nanoplatforms for cancer theranostics (13 papers) and Epigenetics and DNA Methylation (12 papers). The work is most often cited by research in Cancer Research (1.8k citations), Molecular Biology (3.2k citations), Immunology (578 citations), Hepatology (217 citations) and Oncology (618 citations). Kai Li has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Huanjie Yang, Qinghua Zhao, Jianlin Shi, Yu Chen, Ming Ma, Hangrong Chen, Shige Wang, Jingwei Feng, Bin Liu and Qingzhu Yang. Their work appears in journals such as Frontiers in Oncology, Cell Death and Disease, Journal of Cellular Physiology, Acta Biochimica et Biophysica Sinica and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact